Zimmer Biomet adds 178 Florida jobs; Medication error in half of surgeries, finds study;

@FierceMedDev: ICYMI: Healthcare, wellness drive Philips growth as it works to shed lighting. Report | Follow @FierceMedDev

@VarunSaxena2: ICYMI: J&J device heads say the new med tech innovation model calls for more external partnerships. Article | Follow @VarunSaxena2

@EmilyWFierce: Stanford scientists reveal artificial skin device for prosthetics. Story | Follow @EmilyWFierce

> Zimmer Biomet ($ZBH) reportedly will add 178 jobs at its dental implant facility in Palm Beach Gardens, FL. The move was expected as part of a post-merger restructuring. Story

> A study of more than 275 operations at Massachusetts General Hospital found that one out of two surgeries had medication errors with one-third of these resulting in adverse events or patient harm. More

> York, PA-based hospital WellSpan York has started notifying about 1,300 open-heart surgery patients who were exposed to aerosolized bacteria via a body heater-cooler devices during surgery. The FDA issued a warning about this earlier this month. More

> The Wall Street Journal features a Q&A with uBiome co-founder and CEO Jessica Richman on why consumers would want to monitor their microbiome. Story

Biotech News

@FierceBiotech: GlaxoSmithKline's cardio R&D group records another big PhIII flop. News | Follow @FierceBiotech

@JohnCFierce: Kite Pharma taps Mitch Gold's upstart Alpine for T-cell immuno-tech. Article | Follow @JohnCFierce

> After a big-money Allergan deal, Taris returns with a $32M round and a new pipeline. Item

> After Eli Lilly flop, Merck adds a futility challenge to huge PhIII anacetrapib study. Article

Pharma News

@FiercePharma: Roche's O'Day says portfolio firing well in international markets, Japan a star. FiercePharmaAsia story | Follow @FiercePharma

@CarlyHFierce: "I've heard two CEOs use the word 'bold' in the last couple months..." - DB's Gilbert insinuating a $PFE $AGN tie-up. | Follow @CarlyHFierce

> Novartis shells out $390M to settle specialty pharmacy kickback claims. Report

> Bristol-Myers rides Opdivo, hep C sales to Q3 beat. More

> Senator slaps Valeant for sparse response on pricing decisions. Article

Pharma Manufacturing News

> U.K. cites the GSK China plant that was damaged by explosions. News

> Sun recalls 1M-plus boxes of generic Claritin made at Ohm Labs. Report

> Boehringer's Roxane plant mixes up APIs for blood pressure med. Story

> Lawsuit challenges Cipla's buyout of InvaGen. Item

> Spain's Grifols opening $100M warehouse, labeling operation in Dublin. Article

Drug Delivery News

> MIT: Ultrasound gives GI drugs a quicker delivery with less discomfort. Story

> 'Screen door' through blood-brain barrier gives Parkinson's drugs a way in. More

> Capsugel launches coating-free enteric protection delivery platform for oral meds. News

> FDA approval of Endo and BDSI's painkiller a win for buccal drug delivery. Item

> Flowonix to develop drug delivery implant for Cerebral's neurological candidates. Report

Pharma Asia News

> Tata Institute says paper shows 'early success' in malaria vaccine. More

> Indian health officials slam Lancet editor's comments. Article

> Lilly takes Q3 hits in emerging markets on FX, but Japan shows bright spots. Story

> Roche's O'Day says portfolio firing well in international markets, Japan a star. More

> China's ZAI Lab goes novel in drug development, makes key hire. Report

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.